Top Marijuana Shares in the NASDAQ

Even though greater part of U.S.-based cannabis businesses and several foreign American Depository Receipts (ADRs) trade within https://cbdoiladvice.net the countertop (OTC), a marijuana that is few are exchanged in the NASDAQ. Some investors choose shares which can be noted on the NASDAQ to many other exchanges due to their increased liquidity and tighter spreads set alongside the over-the-counter markets. For instance, whilst the cannabis industry is continuing to grow in present months and years, uplisting from an OTC market to a professional U.S. change happens to be a banner achievement for all marijuana that is rising. (For related reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)

An number that is increasing of organizations are now being noted on reputable U.S. exchanges in the place of being exchanged in the OTC market showing the fast development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ ended up being initial exchange that is electronic is definitely similar to technology and biotechnology. The cannabis organizations from the NASDAQ mirror this, therefore the majority of them run within the area that is biotech of industry. Here you will find the NASDAQ-listed cannabis shares, in alphabetical order, at the time of October 26, 2019, with a failure of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is really a biotech business mixed up in production of medical cannabis drugs. Research and development around Arena’s APD371 may be the main focus for the firm’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is a check that is blank that is currently in a merger contract with Kalyx Development Inc. Kalyx is a number one owning a home rely upon the regulated cannabis industry in america.

Key Takeaways

The cannabis industry, specially the area of cannabis and biotech, is attracting investor attention that is substantial.
Cannabis will be utilized in brand new medications for the treating discomfort and chronic that is many inflammatory, and fibrotic conditions.
Companies will also be developing cannabinoid items for autism range disorders, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (a genetic condition), and amphetamine addiction.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is a clinical-stage biotechnology business focused on developing and commercializing new chemical entities when it comes to indications of discomfort and pruritus (itching). Although most of the company’s clinical-stage services and products target opioid receptors, Cara is performing research that is preclinical cannabinoids to treat neuropathic pain.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The team’s research, development, and production are based around cannabis drugs that seek to take care of chronic, inflammatory, fibrotic, as well as other conditions.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is really A canadian cannabis company. The team has and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced plans to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to invest in its continued expansion but additionally with a well-established partner skilled within the advertising of consumer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is a Boca Raton, Florida-based cannabis business. It distributes a variety of cannabis consumption add-ons and vaporization gear and items to customers that are retail the U.S. and Canada. Furthermore, it operates e-commerce internet sites for extra product product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is creating a profile of cannabinoid medications. These medicines consist of Sativex to treat spasticity pertaining to sclerosis that is multiple cancer tumors discomfort and Epidiolex for the treating youth epilepsy. Sativex is commercialized much more than the usual dozen nations away from united states of america and contains gotten approval that is regulatory some other countries. Epidiolex received FDA approval being a therapy for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of severe, very early beginning epilepsy without good current treatment plans. Other indications show that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is really a clinical-stage biopharmaceutical business that is developing drugs predicated on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based pest administration and plant health items. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now legal to be used on cannabis crops within the Ca cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern age Beverages Corp. is just a maker of beverages produced from yerba mate, green tea leaf, kombucha, and comparable services and products. In current months, modern age has expanded its beverage offerings to incorporate CBD infusions aswell, bringing it to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in might of 2019, rendering it one of the more recent cannabis organizations to list regarding the exchange that is popular. The business happens to be rapidly expanding its manufacturing capability that will manage to produce just as much as 113,000 kilograms of item per by the end of 2019 year.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs within the enforcement sector. The business’s business operations support drug screening through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is yet another entry that is new the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a quick price boost) when it announced the production of a brand new Palmetto make of leisure cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage company that is pharmaceutical from the growth of cannabinoid-based medications. Therapix’s current pipeline includes services and products targeted for the treatment of Tourette problem and mild intellectual disability.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. ended up being initial marijuana-related business to have a short general general public providing (IPO) in america. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis items.

Village Farms Global (NASDAQ:VFF)

Village Farms Global is considered the most cannabis that are recent to begin investing from the NASDAQ. The business’s stocks became designed for trade on February 21, 2019. The organization features a history that is decades-long greenhouse produce manufacturing and has now just recently shifted a number of its focus toward cannabis production.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted from the development of artificial treatments that are cannabinoid transdermal (through your skin) delivery. Their pipeline presently includes two drugs being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.